UCCF-853

CAS No. 625458-06-2

UCCF-853( —— )

Catalog No. M34455 CAS No. 625458-06-2

UCCF-853 is a small-molecule CFTR modulator that can be used to study cystic fibrosis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 43 In Stock
5MG 69 In Stock
10MG 107 In Stock
25MG 180 In Stock
50MG 263 In Stock
100MG 390 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    UCCF-853
  • Note
    Research use only, not for human use.
  • Brief Description
    UCCF-853 is a small-molecule CFTR modulator that can be used to study cystic fibrosis.
  • Description
    UCCF-853 is a CFTR modulator.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    CFTR
  • Recptor
    CFTR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    625458-06-2
  • Formula Weight
    312.67
  • Molecular Formula
    C14H8ClF3N2O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1NC2=CC(=CC=C2N1C=3C=CC=C(Cl)C3)C(F)(F)F
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Nicoletta Pedemonte, et al. Influence of cell background on pharmacological rescue of mutant CFTR. Am J Physiol Cell Physiol. 2010 Apr;298(4):C866-74.?
molnova catalog
related products
  • VX-809

    VX-809 (Lumacaftor, VRT 826809) is a potent CFTR corrector that increases F508del-CFTR-mediated chloride transport amd improves F508del-CFTR maturation in FRT cells with EC50 of 0.1 and 0.5 uM, respectively.

  • SRI-37240

    SRI-37240 is a potent inhibitor of premature termination codons (PTCs) with read-across activity that induces a prolonged pause at the termination codon and inhibits PTCs associated with cystic fibrosis.

  • CFTR corrector 12

    CFTR corrector 12 is a CFTR corrector that rescues all mutant proteins except M760R ABCA3, and can be used to study cystic fibrosis.